{"id":1238,"date":"2020-05-26T00:38:56","date_gmt":"2020-05-26T00:38:56","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=1238"},"modified":"2023-08-29T18:02:04","modified_gmt":"2023-08-29T18:02:04","slug":"prescient-therapeutics-obtains-licences-develop-chimeric-immune-receptor-platform-omnicar","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=1238","title":{"rendered":"Prescient Therapeutics\u83b7\u5f97\u4e86\u5f00\u53d1\u201c\u5d4c\u5408\u514d\u75ab\u53d7\u4f53\u5e73\u53f0\u201dOmniCAR\u7684\u4e24\u4e2a\u5173\u952e\u8bb8\u53ef\u8bc1"},"content":{"rendered":"<p>\u751f\u7269\u6280\u672f\u516c\u53f8<a href=\"http:\/\/smallcaps-production.test\/stocks\/?symbol=PTX&amp;lang=cn\">Prescient Therapeutics (ASX: PTX)<\/a>\u4eca\u5929\u4e0a\u5348\u4ece\u505c\u724c\u4e2d\u6062\u590d\uff0c\u516c\u5e03\u4e86\u4e24\u9879\u91cd\u8981\u7684\u8bb8\u53ef\uff0c\u8fd9\u4e24\u9879\u8bb8\u53ef\u4e0e\u8be5\u516c\u53f8\u7684\u901a\u7528\u514d\u75ab\u53d7\u4f53\u6280\u672f\u5e73\u53f0\u6709\u5173\uff0c\u8be5\u5e73\u53f0\u76ee\u524d\u5904\u4e8e\u4e34\u5e8a\u524d\u5f00\u53d1\u9636\u6bb5\u3002<\/p>\n<p>\u5728\u4e00\u4efd\u9762\u5411\u5e02\u573a\u7684\u58f0\u660e\u4e2d\uff0cPrescient\u5ba3\u5e03\u5df2\u83b7\u5f97\u7f8e\u56fd\u5bbe\u5915\u6cd5\u5c3c\u4e9a\u5927\u5b66(University of Pennsylvania)\u7684\u5168\u7403\u72ec\u5bb6\u6388\u6743\uff0c\u7814\u53d1\u7528\u4e8e\u5f00\u53d1\u521b\u65b0\u7ec6\u80de\u7597\u6cd5\u7684\u521b\u65b0\u901a\u7528\u514d\u75ab\u53d7\u4f53\u5e73\u53f0\u3002<\/p>\n<p>\u4f5c\u4e3a\u8865\u5145\uff0c\u8be5\u516c\u53f8\u8fd8\u83b7\u5f97\u4e86\u82f1\u56fd\u725b\u6d25\u5927\u5b66\u7684\u975e\u72ec\u5bb6\u8bb8\u53ef\uff0c\u4f7f\u7528\u65b0\u578b\u7684SpyTag\/SpyCatcher\u5206\u5b50\u7ed1\u5b9a\u7cfb\u7edf\uff0c\u8fd9\u662f\u4e0e\u5bbe\u5915\u6cd5\u5c3c\u4e9a\u5927\u5b66\u6280\u672f\u7684\u4e92\u8865\u3002<\/p>\n<p>Prescient\u8868\u793a\uff0c\u8be5\u516c\u53f8\u8ba1\u5212\u7ed3\u5408Penn\u7684\u514d\u75ab\u53d7\u4f53\u6280\u672f\u548c\u725b\u6d25\u5927\u5b66\u7684\u5206\u5b50\u7ed3\u5408\u7cfb\u7edf\uff0c\u5efa\u7acb\u4e00\u4e2a\u540d\u4e3aOmniCAR\u7684\u201c\u5d4c\u5408\u901a\u7528\u7ec6\u80de\u6cbb\u7597\u5e73\u53f0\u201d\uff0c\u7528\u4e8e\u5f00\u53d1\u4e0b\u4e00\u4ee3\u7ec6\u80de\u6cbb\u7597\u4ea7\u54c1\uff0c\u5305\u62ec\u4e0b\u4e00\u4ee3CAR-T\u3002<\/p>\n<p>\u534f\u8bae\u6761\u6b3e\u89c4\u5b9a\uff0c\u8bb8\u53ef\u91d1\u5c06\u5305\u62ec\u4e00\u7b14\u672a\u62ab\u9732\u7684\u9884\u4ed8\u6b3e\uff0c\u4ee5\u53ca\u4e0e\u4ea7\u54c1\u5f00\u53d1\u548c\u76d1\u7ba1\u5ba1\u6279\u8fc7\u7a0b\u4e2d\u5173\u952e\u6b65\u9aa4\u7684\u5b8c\u6210\u76f8\u5173\u7684\u884c\u4e1a\u6807\u51c6\u91cc\u7a0b\u7891\uff0c\u4ee5\u53ca\u672a\u6765\u5546\u4e1a\u9500\u552e\u7684\u7279\u8bb8\u6743\u4f7f\u7528\u8d39\u3002<\/p>\n<p>Prescient\u5f3a\u8c03\uff0c\u5176\u6700\u65b0\u7684\u8bb8\u53ef\u534f\u8bae\u662f\u975e\u7a00\u91ca\u6027\u7684\uff0c\u76ee\u524d\u6ca1\u6709\u5b9e\u8d28\u6027\u7684\u8d22\u52a1\u5f71\u54cd\uff0c\u5e76\u5c06\u5728\u516c\u53f8\u76ee\u524d\u7684\u9884\u7b97\u8303\u56f4\u5185\u8fdb\u884c\u3002<\/p>\n<p>\u201c\u8fd9\u662fPrescient\u53d6\u5f97\u7684\u9769\u547d\u6027\u6210\u5c31\uff0c\u4f7f\u8be5\u516c\u53f8\u80fd\u591f\u8fc5\u901f\u63a8\u8fdb\u80bf\u7624\u5b66\u521b\u65b0\u7ec6\u80de\u6cbb\u7597\u4ea7\u54c1\u7684\u5f00\u53d1\uff0c\u201d\u8be5\u516c\u53f8\u9996\u5e2d\u6267\u884c\u5b98Steven Yatomi-Clarke\u8868\u793a\u3002<\/p>\n<p>\u4ed6\u8865\u5145\u8bf4\uff0c\u5982\u679cOmniCAR\u9879\u76ee\u6539\u8fdb\u4e86\u73b0\u6709\u7684\u6cbb\u7597\u5b9e\u4f53\u80bf\u7624\u548c\u6db2\u4f53\u80bf\u7624\u7684\u6280\u672f\uff0c\u90a3\u4e48Prescient\u5c06\u5e26\u6765\u201c\u91cd\u5927\u7684\u533b\u7597\u548c\u5546\u4e1a\u5229\u76ca\u201d\u3002<\/p>\n<p>\u201c\u4e0e\u5bbe\u5915\u6cd5\u5c3c\u4e9a\u5927\u5b66\u548c\u725b\u6d25\u5927\u5b66\u7684\u8bb8\u53ef\u534f\u8bae\u4e0ePrescient\u5f00\u53d1\u4e2a\u6027\u5316\u7ec6\u80de\u6cbb\u7597\u836f\u7269\u7684\u76ee\u6807\u5b8c\u7f8e\u5951\u5408\uff0c\u5e76\u8865\u5145\u4e86\u6211\u4eec\u7684\u9776\u5411\u6cbb\u7597\u7ba1\u9053\u3002\u201d\u6211\u4eec\u5df2\u7ecf\u5728\u5229\u7528\u6211\u4eec\u7684\u9776\u5411\u6cbb\u7597\u6280\u672f\u5728\u5176\u4ed6\u7ec6\u80de\u6cbb\u7597\u65b9\u9762\u7684\u5e94\u7528\u3002\u201dYatomi-Clarke\u5148\u751f\u8bf4\u3002<\/p>\n<h2>\u65b0\u4e00\u4ee3\u764c\u75c7\u7597\u6cd5<\/h2>\n<p>\u764c\u75c7\u6cbb\u7597\u6b63\u9010\u6e10\u53d1\u751f\u53d8\u5316\u2014\u2014\u4ece\u4f20\u7edf\u7684\u6cbb\u7597\u8f6c\u5411\u5bf9\u75c5\u4eba\u81ea\u8eab\u7ec6\u80de\u8fdb\u884c\u57fa\u56e0\u6539\u9020\uff0c\u4ee5\u8bc6\u522b\u5e76\u6740\u6b7b\u90a3\u4e9b\u539f\u672c\u9690\u85cf\u5728\u75c5\u4eba\u514d\u75ab\u7cfb\u7edf\u4e4b\u5916\u7684\u764c\u7ec6\u80de\u3002<\/p>\n<p>\u7136\u800c\uff0c\u6700\u65b0\u4e00\u8f6e\u7684\u7ec6\u80de\u6cbb\u7597\u65b9\u6cd5\u9762\u4e34\u7740\u76f8\u5f53\u5927\u7684\u6311\u6218\uff0c\u5305\u62ec\u5236\u9020\u3001\u5b89\u5168\u548c\u9002\u5e94\u6027\uff0c\u8fd9\u9650\u5236\u4e86\u5b83\u4eec\u7684\u5e7f\u6cdb\u5e94\u7528\u3002<\/p>\n<p>\u66f4\u5177\u4f53\u5730\u8bf4\uff0c\u4e34\u5e8a\u533b\u751f\u4e0d\u80fd\u63a7\u5236\u4f20\u7edf\u7ec6\u80de\u6cbb\u7597\u4ea7\u54c1\u6ce8\u5165\u75c5\u4eba\u540e\uff0c\u4ece\u800c\u4ea7\u751f\u91cd\u5927\u7684\u5b89\u5168\u95ee\u9898\uff0c\u5982\u679c\u6bd2\u6027\u89c2\u5bdf\u3002<\/p>\n<p>\u8bb8\u591a\u4f20\u7edf\u7684\u7ec6\u80de\u7597\u6cd5\u53ea\u80fd\u9488\u5bf9\u5355\u4e00\u7684\u764c\u75c7\u6297\u539f\uff0c\u5f53\u764c\u75c7\u8fdb\u4e00\u6b65\u53d8\u5f02\u6216\u764c\u75c7\u8868\u8fbe\u4e0d\u540c\u7684\u6297\u539f\u65f6\uff0c\u5c31\u4f1a\u9650\u5236\u5b83\u4eec\u7684\u6709\u6548\u6027\uff0c\u8fd9\u5728\u5b9e\u4f53\u80bf\u7624\u4e2d\u5c24\u5176\u91cd\u8981\u3002<\/p>\n<p>\u636ePrescient\u62a5\u9053\uff0c\u8fd9\u4e00\u53d8\u5316\u8d8b\u52bf\u9884\u793a\u7740\u764c\u75c7\u6cbb\u7597\u9886\u57df\u7684\u201c\u8303\u5f0f\u8f6c\u53d8\u201d\uff0c\u5bbe\u5915\u6cd5\u5c3c\u4e9a\u5927\u5b66\u5728\u8fc7\u53bb\u5341\u5e74\u7684\u591a\u9879\u7a81\u7834\u6027\u53d1\u73b0\u4e4b\u540e\uff0c\u88ab\u8ba4\u4e3a\u662f\u8be5\u9886\u57df\u7684\u5148\u9a71\u548c\u5168\u7403\u9886\u5bfc\u8005\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u7684OmniCAR\u8ba1\u5212\u65e8\u5728\u63d0\u9ad8\u5f53\u524d\u4e00\u4ee3CAR\u7597\u6cd5\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\uff0c\u5e76\u5c06\u4f7fPrescient\u7684\u4e0b\u4e00\u4ee3\u7ec6\u80de\u7597\u6cd5\u7684\u5185\u90e8\u5f00\u53d1\u6210\u4e3a\u53ef\u80fd\u3002<\/p>\n<p>\u5bbe\u5915\u6cd5\u5c3c\u4e9a\u5927\u5b66\u526f\u6559\u6388Daniel J Powell Jr\u8bf4:\u201c\u7ec6\u80de\u7597\u6cd5\u7684\u521b\u65b0\u5df2\u7ecf\u88ab\u8bc1\u660e\u662f\u533b\u5b66\u53f2\u4e0a\u4e00\u4e2a\u771f\u6b63\u7684\u8f6c\u6298\u70b9\uff0c\u4f46\u5b83\u5e76\u975e\u6ca1\u6709\u6311\u6218\u3002\u201d<\/p>\n<p>\u4ed6\u8865\u5145\u8bf4:\u201c\u6211\u4eec\u76f8\u4fe1\u8fd9\u79cd\u901a\u7528\u7684\u514d\u75ab\u53d7\u4f53\u5e73\u53f0\u6280\u672f\u6709\u6f5c\u529b\u514b\u670d\u76ee\u524d\u5728\u7ec6\u80de\u6cbb\u7597\u4ea7\u54c1\u5f00\u53d1\u4e2d\u9762\u4e34\u7684\u8bb8\u591a\u6311\u6218\u3002\u201d<\/p>\n<h2>OmniCAR\u7684\u672a\u6765<\/h2>\n<p>\u636ePrescient\u79f0\uff0cOmniCAR\u5e73\u53f0\u65e8\u5728\u514b\u670d\u76ee\u524d\u7ec6\u80de\u7597\u6cd5\u7684\u51e0\u4e2a\u7f3a\u70b9\u3002<\/p>\n<p>OmniCAR\u7684\u65b0\u65b9\u6cd5\u6b63\u5728\u5bfb\u6c42\u521b\u9020\u201c\u6a21\u5757\u5316\u5d4c\u5408\u514d\u75ab\u53d7\u4f53\u7ec6\u80de\u201d\uff0c\u4f7f\u6297\u539f\u8bc6\u522b\u4e0e\u4e0b\u6e38\u4fe1\u53f7\u5206\u79bb\u3002\u8be5\u65b9\u6cd5\u8fd8\u91c7\u7528\u4e86SpyTag\/SpyCatcher\u5171\u4ef7\u7ed3\u5408\u7cfb\u7edf\uff0cPrescient\u5c06\u5176\u63cf\u8ff0\u4e3a\u4e00\u79cd\u201c\u5206\u5b50\u9b54\u672f\u8d34\u201d\uff0c\u53ef\u4ee5\u7ed3\u5408\u5230\u5176\u76ee\u6807\u3002<\/p>\n<p>\u6b64\u5916,OmniCAR\u65e8\u5728\u63d0\u4f9b\u63a7\u5236\u548c\u7075\u6d3b\u6027\u662f\u5f53\u524d\u5355\u5143\u683c\u7684\u6cbb\u7597\u50cfCAR-T Prescient\u58f0\u79f0\u5e73\u53f0\u88ab\u5f00\u53d1\u4e3a\u4e34\u5e8a\u533b\u751f\u63d0\u4f9b\u63a7\u5236\u4f53\u5185\u7ec6\u80de\u7597\u6cd5\u7684\u8868\u8fbe\u5f0f,\u901a\u8fc7\u5141\u8bb8\u4ed6\u4eec\u8c03\u6574\u5411\u4e0a\u6216\u5411\u4e0b\u548c\u7ec6\u80de\u7597\u6cd5\u7684\u6d3b\u52a8\u3002<\/p>\n<p>\u8fd9\u4e5f\u4f7f\u4e34\u5e8a\u533b\u751f\u80fd\u591f\u901a\u8fc7\u505c\u6b62\u4f7f\u7528\u7c98\u5408\u5242\uff0c\u6216\u6362\u53e5\u8bdd\u8bf4\uff0c\u4e00\u4e2a\u5185\u7f6e\u7684\u201c\u5173\u95ed\u5f00\u5173\u201d\uff0c\u6765\u5b8c\u5168\u5173\u95ed\u7ec6\u80de\u6cbb\u7597\u6d3b\u52a8\u3002<\/p>\n<p>OmniCAR\u4e5f\u53ef\u4ee5\u53d1\u5c55\u6210\u4e3a\u4e0e\u5305\u62ecT\u7ec6\u80de\u3001NK\u7ec6\u80de\u3001\u5de8\u566c\u7ec6\u80de\u548c\u5e72\u7ec6\u80de\u5728\u5185\u7684\u66ff\u4ee3\u7ec6\u80de\u6cbb\u7597\u65b9\u6cd5\u76f8\u517c\u5bb9\u3002<\/p>\n<p>\u201d\u4f5c\u4e3a\u884c\u4e1a\u8bd5\u56fe\u964d\u4f4e\u7684\u6210\u672c\u548c\u65f6\u95f4\u5bf9\u75c5\u4eba\u63d0\u4f9b\u7ec6\u80de\u7597\u6cd5\u4ea7\u54c1,OmniCAR\u7684\u7075\u6d3b\u6027\u548c\u63a7\u5236\u5c06\u8d8a\u6765\u8d8a\u6709\u4ef7\u503c\u7684\u5de5\u5177,\u901a\u8fc7\u5bfb\u6c42\u6d88\u9664\u591a\u4e2a\u751f\u4ea7\u8fd0\u884c\u6bcf\u4e2a\u75c5\u4eba\u7684\u9700\u8981,\u53ca\u5176\u6f5c\u5728\u7684\u517c\u5bb9\u73b0\u6210\u7684\u7ec6\u80de\u7597\u6cd5\u4ea7\u54c1,\u201d\u8be5\u516c\u53f8\u8868\u793a\u3002<\/p>\n<p>\u5728\u65e9\u76d8\u4ea4\u6613\u4e2d\uff0cPrescient\u7684\u80a1\u4ef7\u4e0a\u6da831%\uff0c\u81f30.059\u6fb3\u5143\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u751f\u7269\u6280\u672f\u516c\u53f8Prescient Therapeutics (ASX: PTX)\u4eca\u5929\u4e0a\u5348\u4ece\u505c\u724c\u4e2d\u6062\u590d\uff0c\u516c\u5e03\u4e86\u4e24\u9879\u91cd\u8981\u7684\u8bb8\u53ef\uff0c\u8fd9\u4e24\u9879\u8bb8\u53ef\u4e0e\u8be5\u516c\u53f8\u7684\u901a\u7528\u514d\u75ab\u53d7\u4f53\u6280\u672f\u5e73\u53f0\u6709\u5173\uff0c\u8be5\u5e73\u53f0\u76ee\u524d\u5904\u4e8e\u4e34\u5e8a\u524d\u5f00\u53d1\u9636\u6bb5\u3002 \u5728\u4e00\u4efd\u9762\u5411\u5e02\u573a\u7684\u58f0\u660e\u4e2d\uff0cPrescient\u5ba3\u5e03\u5df2\u83b7\u5f97\u7f8e\u56fd\u5bbe\u5915\u6cd5\u5c3c\u4e9a\u5927\u5b66(University of Pennsylvania)\u7684\u5168\u7403\u72ec\u5bb6\u6388\u6743\uff0c\u7814\u53d1\u7528\u4e8e\u5f00\u53d1\u521b\u65b0\u7ec6\u80de\u7597\u6cd5\u7684\u521b\u65b0\u901a\u7528\u514d\u75ab\u53d7\u4f53\u5e73\u53f0\u3002 \u4f5c\u4e3a\u8865\u5145\uff0c\u8be5\u516c\u53f8\u8fd8\u83b7\u5f97\u4e86\u82f1\u56fd\u725b\u6d25\u5927\u5b66\u7684\u975e\u72ec\u5bb6\u8bb8\u53ef\uff0c\u4f7f\u7528\u65b0\u578b\u7684SpyTag\/SpyCatcher\u5206\u5b50\u7ed1\u5b9a\u7cfb\u7edf\uff0c\u8fd9\u662f\u4e0e\u5bbe\u5915\u6cd5\u5c3c\u4e9a\u5927\u5b66\u6280\u672f\u7684\u4e92\u8865\u3002 Prescient\u8868\u793a\uff0c\u8be5\u516c\u53f8\u8ba1\u5212\u7ed3\u5408Penn\u7684\u514d\u75ab\u53d7\u4f53\u6280\u672f\u548c\u725b\u6d25\u5927\u5b66\u7684\u5206\u5b50\u7ed3\u5408\u7cfb\u7edf\uff0c\u5efa\u7acb\u4e00\u4e2a\u540d\u4e3aOmniCAR\u7684\u201c\u5d4c\u5408\u901a\u7528\u7ec6\u80de\u6cbb\u7597\u5e73\u53f0\u201d\uff0c\u7528\u4e8e\u5f00\u53d1\u4e0b\u4e00\u4ee3\u7ec6\u80de\u6cbb\u7597\u4ea7\u54c1\uff0c\u5305\u62ec\u4e0b\u4e00\u4ee3CAR-T\u3002 \u534f\u8bae\u6761\u6b3e\u89c4\u5b9a\uff0c\u8bb8\u53ef\u91d1\u5c06\u5305\u62ec\u4e00\u7b14\u672a\u62ab\u9732\u7684\u9884\u4ed8\u6b3e\uff0c\u4ee5\u53ca\u4e0e\u4ea7\u54c1\u5f00\u53d1\u548c\u76d1\u7ba1\u5ba1\u6279\u8fc7\u7a0b\u4e2d\u5173\u952e\u6b65\u9aa4\u7684\u5b8c\u6210\u76f8\u5173\u7684\u884c\u4e1a\u6807\u51c6\u91cc\u7a0b\u7891\uff0c\u4ee5\u53ca\u672a\u6765\u5546\u4e1a\u9500\u552e\u7684\u7279\u8bb8\u6743\u4f7f\u7528\u8d39\u3002 Prescient\u5f3a\u8c03\uff0c\u5176\u6700\u65b0\u7684\u8bb8\u53ef\u534f\u8bae\u662f\u975e\u7a00\u91ca\u6027\u7684\uff0c\u76ee\u524d\u6ca1\u6709\u5b9e\u8d28\u6027\u7684\u8d22\u52a1\u5f71\u54cd\uff0c\u5e76\u5c06\u5728\u516c\u53f8\u76ee\u524d\u7684\u9884\u7b97\u8303\u56f4\u5185\u8fdb\u884c\u3002 \u201c\u8fd9\u662fPrescient\u53d6\u5f97\u7684\u9769\u547d\u6027\u6210\u5c31\uff0c\u4f7f\u8be5\u516c\u53f8\u80fd\u591f\u8fc5\u901f\u63a8\u8fdb\u80bf\u7624\u5b66\u521b\u65b0\u7ec6\u80de\u6cbb\u7597\u4ea7\u54c1\u7684\u5f00\u53d1\uff0c\u201d\u8be5\u516c\u53f8\u9996\u5e2d\u6267\u884c\u5b98Steven Yatomi-Clarke\u8868\u793a\u3002 \u4ed6\u8865\u5145\u8bf4\uff0c\u5982\u679cOmniCAR\u9879\u76ee\u6539\u8fdb\u4e86\u73b0\u6709\u7684\u6cbb\u7597\u5b9e\u4f53\u80bf\u7624\u548c\u6db2\u4f53\u80bf\u7624\u7684\u6280\u672f\uff0c\u90a3\u4e48Prescient\u5c06\u5e26\u6765\u201c\u91cd\u5927\u7684\u533b\u7597\u548c\u5546\u4e1a\u5229\u76ca\u201d\u3002 \u201c\u4e0e\u5bbe\u5915\u6cd5\u5c3c\u4e9a\u5927\u5b66\u548c\u725b\u6d25\u5927\u5b66\u7684\u8bb8\u53ef\u534f\u8bae\u4e0ePrescient\u5f00\u53d1\u4e2a\u6027\u5316\u7ec6\u80de\u6cbb\u7597\u836f\u7269\u7684\u76ee\u6807\u5b8c\u7f8e\u5951\u5408\uff0c\u5e76\u8865\u5145\u4e86\u6211\u4eec\u7684\u9776\u5411\u6cbb\u7597\u7ba1\u9053\u3002\u201d\u6211\u4eec\u5df2\u7ecf\u5728\u5229\u7528\u6211\u4eec\u7684\u9776\u5411\u6cbb\u7597\u6280\u672f\u5728\u5176\u4ed6\u7ec6\u80de\u6cbb\u7597\u65b9\u9762\u7684\u5e94\u7528\u3002\u201dYatomi-Clarke\u5148\u751f\u8bf4\u3002 \u65b0\u4e00\u4ee3\u764c\u75c7\u7597\u6cd5 \u764c\u75c7\u6cbb\u7597\u6b63\u9010\u6e10\u53d1\u751f\u53d8\u5316\u2014\u2014\u4ece\u4f20\u7edf\u7684\u6cbb\u7597\u8f6c\u5411\u5bf9\u75c5\u4eba\u81ea\u8eab\u7ec6\u80de\u8fdb\u884c\u57fa\u56e0\u6539\u9020\uff0c\u4ee5\u8bc6\u522b\u5e76\u6740\u6b7b\u90a3\u4e9b\u539f\u672c\u9690\u85cf\u5728\u75c5\u4eba\u514d\u75ab\u7cfb\u7edf\u4e4b\u5916\u7684\u764c\u7ec6\u80de\u3002 \u7136\u800c\uff0c\u6700\u65b0\u4e00\u8f6e\u7684\u7ec6\u80de\u6cbb\u7597\u65b9\u6cd5\u9762\u4e34\u7740\u76f8\u5f53\u5927\u7684\u6311\u6218\uff0c\u5305\u62ec\u5236\u9020\u3001\u5b89\u5168\u548c\u9002\u5e94\u6027\uff0c\u8fd9\u9650\u5236\u4e86\u5b83\u4eec\u7684\u5e7f\u6cdb\u5e94\u7528\u3002 \u66f4\u5177\u4f53\u5730\u8bf4\uff0c\u4e34\u5e8a\u533b\u751f\u4e0d\u80fd\u63a7\u5236\u4f20\u7edf\u7ec6\u80de\u6cbb\u7597\u4ea7\u54c1\u6ce8\u5165\u75c5\u4eba\u540e\uff0c\u4ece\u800c\u4ea7\u751f\u91cd\u5927\u7684\u5b89\u5168\u95ee\u9898\uff0c\u5982\u679c\u6bd2\u6027\u89c2\u5bdf\u3002 \u8bb8\u591a\u4f20\u7edf\u7684\u7ec6\u80de\u7597\u6cd5\u53ea\u80fd\u9488\u5bf9\u5355\u4e00\u7684\u764c\u75c7\u6297\u539f\uff0c\u5f53\u764c\u75c7\u8fdb\u4e00\u6b65\u53d8\u5f02\u6216\u764c\u75c7\u8868\u8fbe\u4e0d\u540c\u7684\u6297\u539f\u65f6\uff0c\u5c31\u4f1a\u9650\u5236\u5b83\u4eec\u7684\u6709\u6548\u6027\uff0c\u8fd9\u5728\u5b9e\u4f53\u80bf\u7624\u4e2d\u5c24\u5176\u91cd\u8981\u3002 \u636ePrescient\u62a5\u9053\uff0c\u8fd9\u4e00\u53d8\u5316\u8d8b\u52bf\u9884\u793a\u7740\u764c\u75c7\u6cbb\u7597\u9886\u57df\u7684\u201c\u8303\u5f0f\u8f6c\u53d8\u201d\uff0c\u5bbe\u5915\u6cd5\u5c3c\u4e9a\u5927\u5b66\u5728\u8fc7\u53bb\u5341\u5e74\u7684\u591a\u9879\u7a81\u7834\u6027\u53d1\u73b0\u4e4b\u540e\uff0c\u88ab\u8ba4\u4e3a\u662f\u8be5\u9886\u57df\u7684\u5148\u9a71\u548c\u5168\u7403\u9886\u5bfc\u8005\u3002 \u8be5\u516c\u53f8\u7684OmniCAR\u8ba1\u5212\u65e8\u5728\u63d0\u9ad8\u5f53\u524d\u4e00\u4ee3CAR\u7597\u6cd5\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\uff0c\u5e76\u5c06\u4f7fPrescient\u7684\u4e0b\u4e00\u4ee3\u7ec6\u80de\u7597\u6cd5\u7684\u5185\u90e8\u5f00\u53d1\u6210\u4e3a\u53ef\u80fd\u3002 \u5bbe\u5915\u6cd5\u5c3c\u4e9a\u5927\u5b66\u526f\u6559\u6388Daniel J Powell Jr\u8bf4:\u201c\u7ec6\u80de\u7597\u6cd5\u7684\u521b\u65b0\u5df2\u7ecf\u88ab\u8bc1\u660e\u662f\u533b\u5b66\u53f2\u4e0a\u4e00\u4e2a\u771f\u6b63\u7684\u8f6c\u6298\u70b9\uff0c\u4f46\u5b83\u5e76\u975e\u6ca1\u6709\u6311\u6218\u3002\u201d \u4ed6\u8865\u5145\u8bf4:\u201c\u6211\u4eec\u76f8\u4fe1\u8fd9\u79cd\u901a\u7528\u7684\u514d\u75ab\u53d7\u4f53\u5e73\u53f0\u6280\u672f\u6709\u6f5c\u529b\u514b\u670d\u76ee\u524d\u5728\u7ec6\u80de\u6cbb\u7597\u4ea7\u54c1\u5f00\u53d1\u4e2d\u9762\u4e34\u7684\u8bb8\u591a\u6311\u6218\u3002\u201d OmniCAR\u7684\u672a\u6765 \u636ePrescient\u79f0\uff0cOmniCAR\u5e73\u53f0\u65e8\u5728\u514b\u670d\u76ee\u524d\u7ec6\u80de\u7597\u6cd5\u7684\u51e0\u4e2a\u7f3a\u70b9\u3002 OmniCAR\u7684\u65b0\u65b9\u6cd5\u6b63\u5728\u5bfb\u6c42\u521b\u9020\u201c\u6a21\u5757\u5316\u5d4c\u5408\u514d\u75ab\u53d7\u4f53\u7ec6\u80de\u201d\uff0c\u4f7f\u6297\u539f\u8bc6\u522b\u4e0e\u4e0b\u6e38\u4fe1\u53f7\u5206\u79bb\u3002\u8be5\u65b9\u6cd5\u8fd8\u91c7\u7528\u4e86SpyTag\/SpyCatcher\u5171\u4ef7\u7ed3\u5408\u7cfb\u7edf\uff0cPrescient\u5c06\u5176\u63cf\u8ff0\u4e3a\u4e00\u79cd\u201c\u5206\u5b50\u9b54\u672f\u8d34\u201d\uff0c\u53ef\u4ee5\u7ed3\u5408\u5230\u5176\u76ee\u6807\u3002 \u6b64\u5916,OmniCAR\u65e8\u5728\u63d0\u4f9b\u63a7\u5236\u548c\u7075\u6d3b\u6027\u662f\u5f53\u524d\u5355\u5143\u683c\u7684\u6cbb\u7597\u50cfCAR-T Prescient\u58f0\u79f0\u5e73\u53f0\u88ab\u5f00\u53d1\u4e3a\u4e34\u5e8a\u533b\u751f\u63d0\u4f9b\u63a7\u5236\u4f53\u5185\u7ec6\u80de\u7597\u6cd5\u7684\u8868\u8fbe\u5f0f,\u901a\u8fc7\u5141\u8bb8\u4ed6\u4eec\u8c03\u6574\u5411\u4e0a\u6216\u5411\u4e0b\u548c\u7ec6\u80de\u7597\u6cd5\u7684\u6d3b\u52a8\u3002 \u8fd9\u4e5f\u4f7f\u4e34\u5e8a\u533b\u751f\u80fd\u591f\u901a\u8fc7\u505c\u6b62\u4f7f\u7528\u7c98\u5408\u5242\uff0c\u6216\u6362\u53e5\u8bdd\u8bf4\uff0c\u4e00\u4e2a\u5185\u7f6e\u7684\u201c\u5173\u95ed\u5f00\u5173\u201d\uff0c\u6765\u5b8c\u5168\u5173\u95ed\u7ec6\u80de\u6cbb\u7597\u6d3b\u52a8\u3002 OmniCAR\u4e5f\u53ef\u4ee5\u53d1\u5c55\u6210\u4e3a\u4e0e\u5305\u62ecT\u7ec6\u80de\u3001NK\u7ec6\u80de\u3001\u5de8\u566c\u7ec6\u80de\u548c\u5e72\u7ec6\u80de\u5728\u5185\u7684\u66ff\u4ee3\u7ec6\u80de\u6cbb\u7597\u65b9\u6cd5\u76f8\u517c\u5bb9\u3002 \u201d\u4f5c\u4e3a\u884c\u4e1a\u8bd5\u56fe\u964d\u4f4e\u7684\u6210\u672c\u548c\u65f6\u95f4\u5bf9\u75c5\u4eba\u63d0\u4f9b\u7ec6\u80de\u7597\u6cd5\u4ea7\u54c1,OmniCAR\u7684\u7075\u6d3b\u6027\u548c\u63a7\u5236\u5c06\u8d8a\u6765\u8d8a\u6709\u4ef7\u503c\u7684\u5de5\u5177,\u901a\u8fc7\u5bfb\u6c42\u6d88\u9664\u591a\u4e2a\u751f\u4ea7\u8fd0\u884c\u6bcf\u4e2a\u75c5\u4eba\u7684\u9700\u8981,\u53ca\u5176\u6f5c\u5728\u7684\u517c\u5bb9\u73b0\u6210\u7684\u7ec6\u80de\u7597\u6cd5\u4ea7\u54c1,\u201d\u8be5\u516c\u53f8\u8868\u793a\u3002 \u5728\u65e9\u76d8\u4ea4\u6613\u4e2d\uff0cPrescient\u7684\u80a1\u4ef7\u4e0a\u6da831%\uff0c\u81f30.059\u6fb3\u5143\u3002<\/p>\n","protected":false},"author":5,"featured_media":7982,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[171],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Prescient Therapeutics\u83b7\u5f97\u4e86\u5f00\u53d1\u201c\u5d4c\u5408\u514d\u75ab\u53d7\u4f53\u5e73\u53f0\u201dOmniCAR\u7684\u4e24\u4e2a\u5173\u952e\u8bb8\u53ef\u8bc1<\/title>\n<meta name=\"description\" content=\"\u751f\u7269\u6280\u672f\u516c\u53f8Prescient Therapeutics (ASX: PTX)\u4eca\u5929\u4e0a\u5348\u4ece\u505c\u724c\u4e2d\u6062\u590d\uff0c\u516c\u5e03\u4e86\u4e24\u9879\u91cd\u8981\u7684\u8bb8\u53ef\uff0c\u8fd9\u4e24\u9879\u8bb8\u53ef\u4e0e\u8be5\u516c\u53f8\u7684\u901a\u7528\u514d\u75ab\u53d7\u4f53\u6280\u672f\u5e73\u53f0\u6709\u5173\uff0c\u8be5\u5e73\u53f0\u76ee\u524d\u5904\u4e8e\u4e34\u5e8a\u524d\u5f00\u53d1\u9636\u6bb5\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prescient Therapeutics\u83b7\u5f97\u4e86\u5f00\u53d1\u201c\u5d4c\u5408\u514d\u75ab\u53d7\u4f53\u5e73\u53f0\u201dOmniCAR\u7684\u4e24\u4e2a\u5173\u952e\u8bb8\u53ef\u8bc1\" \/>\n<meta property=\"og:description\" content=\"\u751f\u7269\u6280\u672f\u516c\u53f8Prescient Therapeutics (ASX: PTX)\u4eca\u5929\u4e0a\u5348\u4ece\u505c\u724c\u4e2d\u6062\u590d\uff0c\u516c\u5e03\u4e86\u4e24\u9879\u91cd\u8981\u7684\u8bb8\u53ef\uff0c\u8fd9\u4e24\u9879\u8bb8\u53ef\u4e0e\u8be5\u516c\u53f8\u7684\u901a\u7528\u514d\u75ab\u53d7\u4f53\u6280\u672f\u5e73\u53f0\u6709\u5173\uff0c\u8be5\u5e73\u53f0\u76ee\u524d\u5904\u4e8e\u4e34\u5e8a\u524d\u5f00\u53d1\u9636\u6bb5\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-obtains-licences-develop-chimeric-immune-receptor-platform-omnicar\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2020-05-26T00:38:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T18:02:04+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/05\/Prescient-Therapeutics-ASX-PTX-University-of-Pennsylvania-Oxford-University-OmniCAR-cancer.jpg\" \/>\n<meta name=\"author\" content=\"Small Caps\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Prescient Therapeutics\u83b7\u5f97\u4e86\u5f00\u53d1\u201c\u5d4c\u5408\u514d\u75ab\u53d7\u4f53\u5e73\u53f0\u201dOmniCAR\u7684\u4e24\u4e2a\u5173\u952e\u8bb8\u53ef\u8bc1\" \/>\n<meta name=\"twitter:description\" content=\"\u751f\u7269\u6280\u672f\u516c\u53f8Prescient Therapeutics (ASX: PTX)\u4eca\u5929\u4e0a\u5348\u4ece\u505c\u724c\u4e2d\u6062\u590d\uff0c\u516c\u5e03\u4e86\u4e24\u9879\u91cd\u8981\u7684\u8bb8\u53ef\uff0c\u8fd9\u4e24\u9879\u8bb8\u53ef\u4e0e\u8be5\u516c\u53f8\u7684\u901a\u7528\u514d\u75ab\u53d7\u4f53\u6280\u672f\u5e73\u53f0\u6709\u5173\uff0c\u8be5\u5e73\u53f0\u76ee\u524d\u5904\u4e8e\u4e34\u5e8a\u524d\u5f00\u53d1\u9636\u6bb5\u3002\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/05\/Prescient-Therapeutics-ASX-PTX-University-of-Pennsylvania-Oxford-University-OmniCAR-cancer.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Small Caps\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-obtains-licences-develop-chimeric-immune-receptor-platform-omnicar\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-obtains-licences-develop-chimeric-immune-receptor-platform-omnicar\/\",\"name\":\"Prescient Therapeutics\u83b7\u5f97\u4e86\u5f00\u53d1\u201c\u5d4c\u5408\u514d\u75ab\u53d7\u4f53\u5e73\u53f0\u201dOmniCAR\u7684\u4e24\u4e2a\u5173\u952e\u8bb8\u53ef\u8bc1\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2020-05-26T00:38:56+00:00\",\"dateModified\":\"2023-08-29T18:02:04+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\"},\"description\":\"\u751f\u7269\u6280\u672f\u516c\u53f8Prescient Therapeutics (ASX: PTX)\u4eca\u5929\u4e0a\u5348\u4ece\u505c\u724c\u4e2d\u6062\u590d\uff0c\u516c\u5e03\u4e86\u4e24\u9879\u91cd\u8981\u7684\u8bb8\u53ef\uff0c\u8fd9\u4e24\u9879\u8bb8\u53ef\u4e0e\u8be5\u516c\u53f8\u7684\u901a\u7528\u514d\u75ab\u53d7\u4f53\u6280\u672f\u5e73\u53f0\u6709\u5173\uff0c\u8be5\u5e73\u53f0\u76ee\u524d\u5904\u4e8e\u4e34\u5e8a\u524d\u5f00\u53d1\u9636\u6bb5\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-obtains-licences-develop-chimeric-immune-receptor-platform-omnicar\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-obtains-licences-develop-chimeric-immune-receptor-platform-omnicar\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-obtains-licences-develop-chimeric-immune-receptor-platform-omnicar\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Prescient Therapeutics\u83b7\u5f97\u4e86\u5f00\u53d1\u201c\u5d4c\u5408\u514d\u75ab\u53d7\u4f53\u5e73\u53f0\u201dOmniCAR\u7684\u4e24\u4e2a\u5173\u952e\u8bb8\u53ef\u8bc1\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\",\"name\":\"Small Caps\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"caption\":\"Small Caps\"},\"description\":\"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=5\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Prescient Therapeutics\u83b7\u5f97\u4e86\u5f00\u53d1\u201c\u5d4c\u5408\u514d\u75ab\u53d7\u4f53\u5e73\u53f0\u201dOmniCAR\u7684\u4e24\u4e2a\u5173\u952e\u8bb8\u53ef\u8bc1","description":"\u751f\u7269\u6280\u672f\u516c\u53f8Prescient Therapeutics (ASX: PTX)\u4eca\u5929\u4e0a\u5348\u4ece\u505c\u724c\u4e2d\u6062\u590d\uff0c\u516c\u5e03\u4e86\u4e24\u9879\u91cd\u8981\u7684\u8bb8\u53ef\uff0c\u8fd9\u4e24\u9879\u8bb8\u53ef\u4e0e\u8be5\u516c\u53f8\u7684\u901a\u7528\u514d\u75ab\u53d7\u4f53\u6280\u672f\u5e73\u53f0\u6709\u5173\uff0c\u8be5\u5e73\u53f0\u76ee\u524d\u5904\u4e8e\u4e34\u5e8a\u524d\u5f00\u53d1\u9636\u6bb5\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Prescient Therapeutics\u83b7\u5f97\u4e86\u5f00\u53d1\u201c\u5d4c\u5408\u514d\u75ab\u53d7\u4f53\u5e73\u53f0\u201dOmniCAR\u7684\u4e24\u4e2a\u5173\u952e\u8bb8\u53ef\u8bc1","og_description":"\u751f\u7269\u6280\u672f\u516c\u53f8Prescient Therapeutics (ASX: PTX)\u4eca\u5929\u4e0a\u5348\u4ece\u505c\u724c\u4e2d\u6062\u590d\uff0c\u516c\u5e03\u4e86\u4e24\u9879\u91cd\u8981\u7684\u8bb8\u53ef\uff0c\u8fd9\u4e24\u9879\u8bb8\u53ef\u4e0e\u8be5\u516c\u53f8\u7684\u901a\u7528\u514d\u75ab\u53d7\u4f53\u6280\u672f\u5e73\u53f0\u6709\u5173\uff0c\u8be5\u5e73\u53f0\u76ee\u524d\u5904\u4e8e\u4e34\u5e8a\u524d\u5f00\u53d1\u9636\u6bb5\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-obtains-licences-develop-chimeric-immune-receptor-platform-omnicar\/","og_site_name":"smallcapsCN","article_published_time":"2020-05-26T00:38:56+00:00","article_modified_time":"2023-08-29T18:02:04+00:00","og_image":[{"url":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/05\/Prescient-Therapeutics-ASX-PTX-University-of-Pennsylvania-Oxford-University-OmniCAR-cancer.jpg"}],"author":"Small Caps","twitter_card":"summary_large_image","twitter_title":"Prescient Therapeutics\u83b7\u5f97\u4e86\u5f00\u53d1\u201c\u5d4c\u5408\u514d\u75ab\u53d7\u4f53\u5e73\u53f0\u201dOmniCAR\u7684\u4e24\u4e2a\u5173\u952e\u8bb8\u53ef\u8bc1","twitter_description":"\u751f\u7269\u6280\u672f\u516c\u53f8Prescient Therapeutics (ASX: PTX)\u4eca\u5929\u4e0a\u5348\u4ece\u505c\u724c\u4e2d\u6062\u590d\uff0c\u516c\u5e03\u4e86\u4e24\u9879\u91cd\u8981\u7684\u8bb8\u53ef\uff0c\u8fd9\u4e24\u9879\u8bb8\u53ef\u4e0e\u8be5\u516c\u53f8\u7684\u901a\u7528\u514d\u75ab\u53d7\u4f53\u6280\u672f\u5e73\u53f0\u6709\u5173\uff0c\u8be5\u5e73\u53f0\u76ee\u524d\u5904\u4e8e\u4e34\u5e8a\u524d\u5f00\u53d1\u9636\u6bb5\u3002","twitter_image":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/05\/Prescient-Therapeutics-ASX-PTX-University-of-Pennsylvania-Oxford-University-OmniCAR-cancer.jpg","twitter_misc":{"Written by":"Small Caps"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-obtains-licences-develop-chimeric-immune-receptor-platform-omnicar\/","url":"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-obtains-licences-develop-chimeric-immune-receptor-platform-omnicar\/","name":"Prescient Therapeutics\u83b7\u5f97\u4e86\u5f00\u53d1\u201c\u5d4c\u5408\u514d\u75ab\u53d7\u4f53\u5e73\u53f0\u201dOmniCAR\u7684\u4e24\u4e2a\u5173\u952e\u8bb8\u53ef\u8bc1","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2020-05-26T00:38:56+00:00","dateModified":"2023-08-29T18:02:04+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74"},"description":"\u751f\u7269\u6280\u672f\u516c\u53f8Prescient Therapeutics (ASX: PTX)\u4eca\u5929\u4e0a\u5348\u4ece\u505c\u724c\u4e2d\u6062\u590d\uff0c\u516c\u5e03\u4e86\u4e24\u9879\u91cd\u8981\u7684\u8bb8\u53ef\uff0c\u8fd9\u4e24\u9879\u8bb8\u53ef\u4e0e\u8be5\u516c\u53f8\u7684\u901a\u7528\u514d\u75ab\u53d7\u4f53\u6280\u672f\u5e73\u53f0\u6709\u5173\uff0c\u8be5\u5e73\u53f0\u76ee\u524d\u5904\u4e8e\u4e34\u5e8a\u524d\u5f00\u53d1\u9636\u6bb5\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-obtains-licences-develop-chimeric-immune-receptor-platform-omnicar\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-obtains-licences-develop-chimeric-immune-receptor-platform-omnicar\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-obtains-licences-develop-chimeric-immune-receptor-platform-omnicar\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Prescient Therapeutics\u83b7\u5f97\u4e86\u5f00\u53d1\u201c\u5d4c\u5408\u514d\u75ab\u53d7\u4f53\u5e73\u53f0\u201dOmniCAR\u7684\u4e24\u4e2a\u5173\u952e\u8bb8\u53ef\u8bc1"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74","name":"Small Caps","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","caption":"Small Caps"},"description":"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.","url":"https:\/\/smallcapscn.x5view.co\/?author=5"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1238"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1238"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1238\/revisions"}],"predecessor-version":[{"id":7981,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1238\/revisions\/7981"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/7982"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1238"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1238"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1238"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}